Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
12/2000
12/14/2000WO2000075107A2 Bradykinin receptor antagonists
12/14/2000WO2000074742A1 Devices and compounds for treating arterial restenosis
12/14/2000WO2000074724A2 Conjugates comprising cytokines and nucleic acids for treating proliferating cells
12/14/2000WO2000074717A1 NOVEL Ig FRACTIONS HAVING AN IMMUNOMODULATORY ACTIVITY
12/14/2000WO2000074715A1 Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
12/14/2000WO2000074712A2 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
12/14/2000WO2000074706A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000WO2000074703A2 Therapeutic agent comprising a botulinum neurotoxin
12/14/2000WO2000074699A1 Extracts of feverfew (tanacetum parthenium) against inflammatory disorders
12/14/2000WO2000074691A1 Treatment of cutaneous leishmaniasis and other dermatological diseases mainly wounds (diabetic ulcers) by idogenos sanhory
12/14/2000WO2000074687A1 Antisense modulation of b7 protein expression
12/14/2000WO2000074668A1 Non-solid composition for local application
12/14/2000WO2000074641A1 Use of ascorbic acid and one or more flavone derivatives and/or flavan derivatives, especially flavonoids, for producing cosmetic or dermatological preparations used to prevent or sooth sunburns
12/14/2000WO2000074634A2 Methods and compositions for modulating cell proliferation and cell death
12/14/2000WO2000057190A3 Prediction of diabetes impaired wound healing
12/14/2000WO2000050562A3 Dna encoding snorf25 receptor
12/14/2000WO2000050070A3 Preparation for the treatment of pigmentation disorders
12/14/2000WO2000049135A3 Substrate for cell growth
12/14/2000WO2000048615A3 TREATMENT OF CHRONIC VIRAL INFECTIONS WITH $i(M. VACCAE)
12/14/2000WO2000048554B1 Synergistic antimicrobial skin washing compositions
12/14/2000WO2000047758A3 Methods of making compounds
12/14/2000WO2000047716A3 Fibres for culturing eukaryotic cells
12/14/2000WO2000044763A3 Compositions for treating inflammatory response
12/14/2000WO2000006187A9 Modulation of apoptosis
12/14/2000CA2383828A1 26 human secreted proteins
12/14/2000CA2377385A1 Methods and compositions for modulating cell proliferation and cell death
12/14/2000CA2376506A1 Neuromedin b and somatostatin receptor agonists
12/14/2000CA2376335A1 Novel ig fractions having an immunomodulatory activity
12/14/2000CA2376210A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000CA2376078A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/14/2000CA2376048A1 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
12/14/2000CA2376018A1 Angiogenic proteins and uses thereof
12/14/2000CA2376010A1 Mycolactone and related compounds, compositions and methods of use
12/14/2000CA2375843A1 Compositions and methods for inhibiting cell death
12/14/2000CA2375734A1 Benzothiazinone and benzoxazinone compounds
12/14/2000CA2375485A1 Method for multiplying stem cells
12/14/2000CA2374558A1 Phospholipid transfer protein
12/14/2000CA2374256A1 Methods and compounds for the treatment of immunologically-mediated diseases using <i>mycobacterium vaccae</i>
12/13/2000EP1059088A1 New Ig-fractions with immunomodulation activity
12/13/2000EP1058698A1 Preparation for prevention and healing of inflammation affections
12/13/2000EP1058691A1 Caspase-8 interacting proteins
12/13/2000EP1058690A1 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes
12/13/2000EP1058554A2 Nontoxic vernix compositions and method of producing
12/13/2000CN1276782A 2-aminotetralines, process for their preparation, and pharmaceutical compositions, for prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
12/13/2000CN1276729A Heparin-binding growth factor (HBGF) polypeptides
12/13/2000CN1276726A Method for treating hypercoagulable states or acquired protein C deficiency
12/13/2000CN1276715A Method and composition for causing skin lightening
12/13/2000CN1276714A Use of 17-'alpha'-estradiol for treatment of aged or sundamaged skin and./or skin atrophy
12/13/2000CN1276211A Use of non-peptides NK3-antagonist
12/13/2000CN1276205A Turmeric as antiirritant in composition contg. hydroxy acid or retinene derivs.
12/13/2000CN1059340C Burns and scald treating medicine
12/13/2000CN1059334C Oral liquid for treating hand and foot chapping
12/13/2000CN1059332C Medicine for external use for treatment of alopecia areata
12/13/2000CN1059331C Preparation for treatment of alopecia areata
12/13/2000CN1059329C 'Qingsongsan' medicinal liquor or ointment and preparing method thereof
12/13/2000CN1059328C Hair regrowth liquid medicine
12/13/2000CN1059319C Cosmetic and/or dematological composition with hydrophilic carrier and vitamine C which can be mixed before use
12/12/2000US6160021 Administering to the subject a treatment which modulates the level of nitric oxide in the skin
12/12/2000US6160012 Leukotriene B4 derivatives, in particular oximo-LTB4 - antagonists
12/12/2000US6159977 Therapeutic anti-fungal nail preparation
12/12/2000US6159967 such as 1-(2-((2R)-(3,4-dichlorophenyl)-4-(3,4,5-trimethoxybenzoyl) morpholin-2-yl)ethyl)spiro(benzo(c)thiophene-1-(3H), 4'-piperidine)-(2S)-oxide; respiratory disease such as asthma
12/12/2000US6159950 Promoting hair growth on mammals skins, vectors and dna sequences
12/12/2000US6159716 Amino acid sequence of serine/threonine kinase; antiulcer/ anticarcinogenic/antiarthritic agents; treatment of parkinson's/huntigton's diseases, tourette's syndrome, eating disorders, osteoporosis, allergies; diagnosis of disease
12/12/2000US6159697 Antisense modulation of Smad7 expression
12/12/2000US6159503 Comprising a dry cationic pectin salt which when suspended in water swells to heat stable particles
12/12/2000US6159485 Cosmetics; skin disorders
12/12/2000US6159479 Clear, aqueous solution containign polyoxyethylene oxide solubilizer
12/12/2000US6159461 Use of c-kit ligand with TNF-α and hematopoietic factors for the expansion or differentiation of hematopoietic cells
12/12/2000US6159454 Use of cholesteric liquid-crystalline polymers as UV screens in cosmetic and pharmaceutical preparations
12/12/2000CA2168247C Nitric oxide donor composition and method for treatment of anal disorders
12/12/2000CA2167397C Indoles
12/07/2000WO2000073507A2 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
12/07/2000WO2000073450A2 Cytoskeleton-associated proteins
12/07/2000WO2000073445A2 Interleukin-1-receptor associated kinase-3 (irak3)
12/07/2000WO2000073443A1 Lipid metabolism transcription factor
12/07/2000WO2000073374A1 Silicone gel containing salicylic acid
12/07/2000WO2000073342A1 Structural models for cytoplasmic domains of transmembrane receptors
12/07/2000WO2000073327A1 Chemokine receptor ccr3 antagonists
12/07/2000WO2000073324A2 Modulation of gene expression in gastrointestinal inflammation
12/07/2000WO2000073323A2 Adam polynucleotides and polypeptides
12/07/2000WO2000073301A1 Bicyclic oxazolidinones as antibacterial agent
12/07/2000WO2000073295A1 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
12/07/2000WO2000073294A2 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
12/07/2000WO2000073292A1 Biaryl compounds
12/07/2000WO2000073280A1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
12/07/2000WO2000073279A1 4-phenyl-pyrimidine derivatives
12/07/2000WO2000073278A2 5-phenyl-pyrimidine derivatives
12/07/2000WO2000073266A1 Novel antioxidants, preparation methods and uses
12/07/2000WO2000073265A1 Sulfur-containing thyroxane derivatives and their use as hair growth promotors
12/07/2000WO2000073253A1 NOVEL INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR-α MODULATORS, SYNTHESES OF SAID MODULATORS AND METHODS OF USING SAID MODULATORS
12/07/2000WO2000072920A1 Substituted biaryl ether compounds
12/07/2000WO2000072881A1 A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders
12/07/2000WO2000072876A2 Prevention and treatment of amyloidogenic disease
12/07/2000WO2000072872A1 Keratinocyte growth factor-2 formulations
12/07/2000WO2000072863A2 Uses of h-trek-1 polypeptides and polynucleotides encoding them
12/07/2000WO2000072859A1 Balsam for the treatment of surface burns and chafing rashes
12/07/2000WO2000072849A1 Novel epidermal growth factor receptor-binding compounds for positron emission tomography
12/07/2000WO2000072845A1 Il-8 receptor antagonists
12/07/2000WO2000072840A1 Il-8 receptor antagonists
12/07/2000WO2000072822A1 Preparations for the application of anti-infective and/or anti-inflammatory agents
1 ... 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 ... 1065